Sidekick Bio
Cambridge, United States· Est.
Develops small molecule therapeutics targeting RNA-binding proteins for oncology and immunology applications.
Private Company
Total funding raised: $10M
About
Develops small molecule therapeutics targeting RNA-binding proteins for oncology and immunology applications.
Microbiome
Funding History
1Total raised:$10M
Seed$10M